Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NNMT | P40261 | 1/20 | 0.52 |
| ▸ | CD2 | P06729 | 1/20 | 0.50 |
| ▸ | CD58 | P19256 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 4/20 | 0.49 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.49 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.49 |
| ▸ | ITGAV | P06756 | 1/20 | 0.49 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.49 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.49 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | OXTR | P30559 | 1/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.45 |
| ▸ | PLAU | P00749 | 2/20 | 0.45 |
| ▸ | CTSG | P08311 | 2/20 | 0.44 |
| ▸ | TFPI | P10646 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21664075 | 0.80 | NNMT (0.56) | NNMTCD2CD58ELANEITGB3 | |
| SCHEMBL23839922 | 0.77 | ITGB3 (0.56) | CD2CD58ITGB3ITGB1ITGAV | |
| SCHEMBL7746029 | 0.77 | ITGB3 (0.56) | CD2CD58ITGB3ITGB1ITGAV | |
| SCHEMBL24454392 | 0.77 | ITGB3 (0.56) | CD2CD58ITGB3ITGB1ITGAV | |
| SCHEMBL19018807 | 0.77 | ITGB3 (0.56) | CD2CD58ITGB3ITGB1ITGAV | |
| SCHEMBL15308347 | 0.77 | ITGB3 (0.56) | CD2CD58ITGB3ITGB1ITGAV | |
| SCHEMBL7743802 | 0.75 | ITGB3 (0.56) | NNMTITGB3ITGB1ITGAVITGA5 | |
| SCHEMBL14585801 | 0.75 | ITGB3 (0.54) | NNMTITGB3ITGB1ITGAVITGA5 | |
| SCHEMBL7744062 | 0.75 | ITGB3 (0.54) | NNMTITGB3ITGB1ITGAVITGA5 | |
| SCHEMBL7743645 | 0.75 | ITGB3 (0.54) | NNMTITGB3ITGB1ITGAVITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | FUJIFILM CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | VIP, NPPA, NGLY1 | NNMT 4267/4885CD2 2880/4885CD58 2643/4885 |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | VIP, NPPA, NGLY1 | NNMT 4267/4885CD2 2880/4885CD58 2643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.